Global Basal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 30642
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 93
  • list Pharmaceuticals and Healthcare

Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.

The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market. 

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are considered as the prominent geographical segments of this market. North America, which is the current market leader, is expected to remain dominant over the next few years. The presence of a well-established medical and healthcare infrastructure, increasing expenditure on healthcare, and the high prevalence of basal cell carcinoma in this region are likely to boost the growth of the market for basal cell carcinoma treatment in North America.

In 2020, the global Basal Cell Carcinoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Basal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Basal Cell Carcinoma Therapeutics development in United States, Europe and China.

The key players covered in this study

Sun Pharmaceuticals

Valeant Pharmaceuticals International

Mylan

F. Hoffmann-La Roche

Merck

...

Market segment by Type, the product can be split into

Surgery

Radiation Therapy

Photodynamic Therapy

Drugs

Market segment by Application, split into

Retail Pharmacies

Hospitals Pharmacies

Cancer Research Institutes

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Basal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players.

To present the Basal Cell Carcinoma Therapeutics development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Basal Cell Carcinoma Therapeutics are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (2015-2026)

1.4.2 Surgery

1.4.3 Radiation Therapy

1.4.4 Photodynamic Therapy

1.4.5 Drugs

1.5 Market by Application

1.5.1 Global Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2026)

1.5.2 Retail Pharmacies

1.5.3 Hospitals Pharmacies

1.5.4 Cancer Research Institutes

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Basal Cell Carcinoma Therapeutics Market Size

2.2 Basal Cell Carcinoma Therapeutics Growth Trends by Regions

2.2.1 Basal Cell Carcinoma Therapeutics Market Size by Regions (2015-2026)

2.2.2 Basal Cell Carcinoma Therapeutics Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Basal Cell Carcinoma Therapeutics Market Size by Manufacturers

3.1.1 Global Basal Cell Carcinoma Therapeutics Revenue by Manufacturers (2015-2020)

3.1.2 Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)

3.2 Basal Cell Carcinoma Therapeutics Key Players Head office and Area Served

3.3 Key Players Basal Cell Carcinoma Therapeutics Product/Solution/Service

3.4 Date of Enter into Basal Cell Carcinoma Therapeutics Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)

4.2 Global Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)

5 United States

5.1 United States Basal Cell Carcinoma Therapeutics Market Size (2015-2020)

5.2 Basal Cell Carcinoma Therapeutics Key Players in United States

5.3 United States Basal Cell Carcinoma Therapeutics Market Size by Type

5.4 United States Basal Cell Carcinoma Therapeutics Market Size by Application

6 Europe

6.1 Europe Basal Cell Carcinoma Therapeutics Market Size (2015-2020)

6.2 Basal Cell Carcinoma Therapeutics Key Players in Europe

6.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Type

6.4 Europe Basal Cell Carcinoma Therapeutics Market Size by Application

7 China

7.1 China Basal Cell Carcinoma Therapeutics Market Size (2015-2020)

7.2 Basal Cell Carcinoma Therapeutics Key Players in China

7.3 China Basal Cell Carcinoma Therapeutics Market Size by Type

7.4 China Basal Cell Carcinoma Therapeutics Market Size by Application

8 Japan

8.1 Japan Basal Cell Carcinoma Therapeutics Market Size (2015-2020)

8.2 Basal Cell Carcinoma Therapeutics Key Players in Japan

8.3 Japan Basal Cell Carcinoma Therapeutics Market Size by Type

8.4 Japan Basal Cell Carcinoma Therapeutics Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size (2015-2020)

9.2 Basal Cell Carcinoma Therapeutics Key Players in Southeast Asia

9.3 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Type

9.4 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Application

10 India

10.1 India Basal Cell Carcinoma Therapeutics Market Size (2015-2020)

10.2 Basal Cell Carcinoma Therapeutics Key Players in India

10.3 India Basal Cell Carcinoma Therapeutics Market Size by Type

10.4 India Basal Cell Carcinoma Therapeutics Market Size by Application

11 Central & South America

11.1 Central & South America Basal Cell Carcinoma Therapeutics Market Size (2015-2020)

11.2 Basal Cell Carcinoma Therapeutics Key Players in Central & South America

11.3 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Type

11.4 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Application

12 International Players Profiles

12.1 Sun Pharmaceuticals

12.1.1 Sun Pharmaceuticals Company Details

12.1.2 Company Description and Business Overview

12.1.3 Basal Cell Carcinoma Therapeutics Introduction

12.1.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)

12.1.5 Sun Pharmaceuticals Recent Development

12.2 Valeant Pharmaceuticals International

12.2.1 Valeant Pharmaceuticals International Company Details

12.2.2 Company Description and Business Overview

12.2.3 Basal Cell Carcinoma Therapeutics Introduction

12.2.4 Valeant Pharmaceuticals International Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)

12.2.5 Valeant Pharmaceuticals International Recent Development

12.3 Mylan

12.3.1 Mylan Company Details

12.3.2 Company Description and Business Overview

12.3.3 Basal Cell Carcinoma Therapeutics Introduction

12.3.4 Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)

12.3.5 Mylan Recent Development

12.4 F. Hoffmann-La Roche

12.4.1 F. Hoffmann-La Roche Company Details

12.4.2 Company Description and Business Overview

12.4.3 Basal Cell Carcinoma Therapeutics Introduction

12.4.4 F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)

12.4.5 F. Hoffmann-La Roche Recent Development

12.5 Merck

12.5.1 Merck Company Details

12.5.2 Company Description and Business Overview

12.5.3 Basal Cell Carcinoma Therapeutics Introduction

12.5.4 Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)

12.5.5 Merck Recent Development

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Basal Cell Carcinoma Therapeutics Key Market Segments

Table Key Players Basal Cell Carcinoma Therapeutics Covered

Table Global Basal Cell Carcinoma Therap